dagblog - Comments for "Drug Prices on TV? They May Be Coming."

Pharmacy benefit management

artappraiser — Tue, 26 Mar 2019 01:14:13 +0000

Pharmacy benefit management (PBM's) From Wikipedia, the free encyclopedia, my underlining

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), and state government employee plans.[1][2][3] As of 2018 they have become industrial behemoths in the US health sector.[4] [.....]

As of 2016, PBMs managed pharmacy benefits for 266 million Americans.[2] PBMs operate inside of integrated healthcare systems (e.g., Kaiser or VA), as part of retail pharmacies (e.g., CVS Pharmacy or Rite-Aid), and as part of insurance companies (e.g., UnitedHealth Group).[1][6] In 2016 there were fewer than 30 major PBM companies in this category in the US,[1] and three major PBMs (Express Scripts, CVS Health, and OptumRx of UnitedHealth Group) comprise 78% of the market and cover 180 million enrollees.[1][7] [.....]

Changing formularies make

artappraiser — Tue, 26 Mar 2019 01:07:34 +0000

In reply to Drug Prices on TV? They May Be Coming.

“Opaque programs can pose an unreasonable and costly administrative obstacle to patient-centered care.” -@JackResneckMD. #FixPriorAuth pic.twitter.com/og7JvwPVVh
— Physicians Grassroots Network (@PhysGrassroots) March 21, 2019

Changing formularies make prescribing difficult and confusing. We need to increase transparency at the point-of-prescribing. Like this tweet if you agree! pic.twitter.com/KS5OoMCUyR
— Physicians Grassroots Network (@PhysGrassroots) March 22, 2019

More than 1 in 4 physicians say #PriorAuthorization has led to a serious adverse event for a patient in their care. @AmerMedicalAssn president @BarbaraMcAneny says it’s time to #FixPriorAuth: https://t.co/d9gjAFWzoj
— Physicians Grassroots Network (@PhysGrassroots) March 21, 2019

We believe drug companies, PBMs and insurers should all take concrete steps to increase drug price transparency. See the details here: https://t.co/Yr2mmnHaRS pic.twitter.com/31e7RLtOZy
— Physicians Grassroots Network (@PhysGrassroots) March 24, 2019

Must-read: Invoking high

artappraiser — Mon, 25 Mar 2019 23:58:38 +0000

In reply to Drug Prices on TV? They May Be Coming.

Must-read: Invoking high research costs to justify high drug prices is deceptive, writes Ezekiel Emanuel in @TheAtlantic. https://t.co/h2VKUX4IEU #drugprices #pharma
— Arnold Ventures (@Arnold_Ventures) March 25, 2019

Me too:

artappraiser — Mon, 25 Mar 2019 23:57:51 +0000

In reply to Drug Prices on TV? They May Be Coming.

Me too:

I'll take the other side of that bet https://t.co/hu6Fm1LuCK
— Jodi Beggs (@jodiecongirl) March 25, 2019